Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4207741
Max Phase: Preclinical
Molecular Formula: C56H88N12O10
Molecular Weight: 1089.39
Molecule Type: Small molecule
Associated Items:
ID: ALA4207741
Max Phase: Preclinical
Molecular Formula: C56H88N12O10
Molecular Weight: 1089.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)C[C@@H](N)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN)NC(=O)[C@H](C(C)C)NC(=O)C[C@@H](N)C(=O)[C@@H](Cc2ccccc2)NC1=O
Standard InChI: InChI=1S/C56H88N12O10/c1-31(2)25-43-53(75)63-41(27-35-17-11-9-12-18-35)49(71)37(59)29-45(69)68-48(34(7)8)56(78)62-40(22-16-24-58)52(74)66-44(26-32(3)4)54(76)64-42(28-36-19-13-10-14-20-36)50(72)38(60)30-46(70)67-47(33(5)6)55(77)61-39(21-15-23-57)51(73)65-43/h9-14,17-20,31-34,37-44,47-48H,15-16,21-30,57-60H2,1-8H3,(H,61,77)(H,62,78)(H,63,75)(H,64,76)(H,65,73)(H,66,74)(H,67,70)(H,68,69)/t37-,38-,39+,40+,41-,42-,43+,44+,47+,48+/m1/s1
Standard InChI Key: MQQQRUYEWYOAJI-WQVXMKQVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1089.39 | Molecular Weight (Monoisotopic): 1088.6746 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wan Y, Stanovych A, Gori D, Zirah S, Kouklovsky C, Alezra V.. (2018) β,γ-diamino acids as building blocks for new analogues of Gramicidin S: Synthesis and biological activity., 149 [PMID:29499484] [10.1016/j.ejmech.2018.02.053] |
Source(1):